Literature DB >> 29057247

Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.

Rafael Soares Lindoso1,2,3, Federica Collino1,2,3, Adalberto Vieyra1,2,3,4.   

Abstract

The tumor microenvironment comprises a heterogeneous population of tumorigenic and non-tumorigenic cells. Cancer stem cells (CSCs) and mesenchymal stem cells (MSCs) are components of this microenvironment and have been described as key regulators of different aspects of tumor physiology. They act differently on the tumor: CSCs are described as tumor initiators and are associated with tumor growth, drug resistance and metastasis; MSCs can integrate the tumor microenvironment after recruitment and interact with cancer cells to promote tumor modifications. Extracellular vesicles (EVs) have emerged as an important mechanism of cell communication under the physiological and pathological conditions. In cancer, secretion of EVs seems to be one of the main mechanisms by which stem cells interact with other tumor and non-tumor cells. The transfer of bioactive molecules (lipids, proteins and RNAs) compartmentalized into EVs triggers different responses in the target cells, regulating several processes in the tumor as angiogenesis, tumor invasiveness and immune escape. This review focuses on the role of CSCs and MSCs in modulating the tumor microenvironment through secretion of EVs, addressing different aspects of the multidirectional interactions among stem cells, tumor and tumor-associated cells.

Entities:  

Keywords:  Anti- and pro-tumorigenic extracellular vesicles (EV); cancer stem cells (CSC); circulating cancer biomarkers; mesenchymal stem cells (MSC); tumor microenvironment

Year:  2017        PMID: 29057247      PMCID: PMC5639036          DOI: 10.21037/sci.2017.08.08

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  127 in total

Review 1.  Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.

Authors:  Jan Paul Medema; Louis Vermeulen
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

2.  ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming.

Authors:  Elodie Segura; Carole Nicco; Bérangère Lombard; Philippe Véron; Graça Raposo; Frédéric Batteux; Sebastian Amigorena; Clotilde Théry
Journal:  Blood       Date:  2005-03-24       Impact factor: 22.113

Review 3.  Membrane budding and scission by the ESCRT machinery: it's all in the neck.

Authors:  James H Hurley; Phyllis I Hanson
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-30       Impact factor: 94.444

Review 4.  MicroRNAs in extracellular vesicles: potential cancer biomarkers.

Authors:  Takashi Kinoshita; Kenneth W Yip; Tara Spence; Fei-Fei Liu
Journal:  J Hum Genet       Date:  2016-07-07       Impact factor: 3.172

5.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

6.  Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

Authors:  O Fourcade; M F Simon; C Viodé; N Rugani; F Leballe; A Ragab; B Fournié; L Sarda; H Chap
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

7.  Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.

Authors:  Haobin Wang; Sanyukta Rana; Nathalia Giese; Markus W Büchler; Margot Zöller
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

8.  Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.

Authors:  Jong-Kuen Lee; Sae-Ra Park; Bong-Kwang Jung; Yoon-Kyung Jeon; Yeong-Shin Lee; Min-Kyoung Kim; Yong-Goo Kim; Ji-Young Jang; Chul-Woo Kim
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 9.  Chronic inflammation and cytokines in the tumor microenvironment.

Authors:  Glauben Landskron; Marjorie De la Fuente; Peti Thuwajit; Chanitra Thuwajit; Marcela A Hermoso
Journal:  J Immunol Res       Date:  2014-05-13       Impact factor: 4.818

10.  Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo.

Authors:  Shuai Wu; Guan-Qun Ju; Tao Du; Ying-Jian Zhu; Guo-Hua Liu
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

View more
  16 in total

1.  Metabolomics studies of cell-cell interactions using single cell mass spectrometry combined with fluorescence microscopy.

Authors:  Xingxiu Chen; Zongkai Peng; Zhibo Yang
Journal:  Chem Sci       Date:  2022-05-16       Impact factor: 9.969

Review 2.  Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases.

Authors:  Milena B P Soares; Renata G J Gonçalves; Juliana F Vasques; Almir J da Silva-Junior; Fernanda Gubert; Girlaine Café Santos; Thaís Alves de Santana; Gabriela Louise Almeida Sampaio; Daniela Nascimento Silva; Massimo Dominici; Rosalia Mendez-Otero
Journal:  Front Mol Neurosci       Date:  2022-06-16       Impact factor: 6.261

Review 3.  The Dual Role of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Carcinogenesis.

Authors:  Zarema Gilazieva; Aleksei Ponomarev; Albert Rizvanov; Valeriya Solovyeva
Journal:  Biology (Basel)       Date:  2022-05-25

Review 4.  Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer.

Authors:  Somayeh Vafaei; Raheleh Roudi; Zahra Madjd; Amir Reza Aref; Marzieh Ebrahimi
Journal:  Cancer Cell Int       Date:  2020-07-06       Impact factor: 5.722

5.  Human Wharton's jelly mesenchymal stem cells-derived secretome could inhibit breast cancer growth in vitro and in vivo.

Authors:  Mansoureh Mirabdollahi; Hojjat Sadeghi-Aliabadi; Shaghayegh Haghjooy Javanmard
Journal:  Iran J Basic Med Sci       Date:  2020-07       Impact factor: 2.699

Review 6.  The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles.

Authors:  Chiara Ciardiello; Alessandra Leone; Alfredo Budillon
Journal:  Stem Cells Int       Date:  2018-11-05       Impact factor: 5.443

Review 7.  Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells.

Authors:  Petra Gener; Joaquin Seras-Franzoso; Patricia González Callejo; Fernanda Andrade; Diana Rafael; Francesc Martínez; Sara Montero; Diego Arango; Joan Sayós; Ibane Abasolo; Simó Schwartz
Journal:  Stem Cells Int       Date:  2018-10-10       Impact factor: 5.443

Review 8.  Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance.

Authors:  Patrick Santos; Fausto Almeida
Journal:  Cells       Date:  2020-06-11       Impact factor: 6.600

Review 9.  Extracellular Vesicles in Hepatobiliary Malignancies.

Authors:  Ainhoa Lapitz; Ander Arbelaiz; Paula Olaizola; Aitziber Aranburu; Luis Bujanda; Maria J Perugorria; Jesus M Banales
Journal:  Front Immunol       Date:  2018-10-12       Impact factor: 7.561

10.  Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome.

Authors:  Trushil Shah; Shanshan Qin; Mona Vashi; Dan N Predescu; Niranjan Jeganathan; Cristina Bardita; Balaji Ganesh; Salvatore diBartolo; Louis F Fogg; Robert A Balk; Sanda A Predescu
Journal:  Clin Transl Med       Date:  2018-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.